Industrial chemical found in Cubicin

Apr 10, 2008

The U.S. Food and Drug Administration said Cubist Pharmaceuticals is warning that an industrial chemical has been found in the antibiotic Cubicin.

Cubist, a Massachusetts-based drug maker, said the chemical 2-mercaptobenzothiazole (MBT) has been found in reconstituted Cubicin stored in ReadyMED pumps, which are made by Cardinal Health. "At this time, Cubist recommends against using ReadyMED elastomeric infusion pumps with Cubicin," Cubist said in a letter to medical professionals last week.

Cubist spokeswoman Eileen McIntyre told The Wall Street Journal the company thinks the contamination came from the drug pumps. Cardinal Health said it is investigating the issue.

Cubist said MBT, which is used in the manufacturing of rubber, was not detected in samples from Eclipse pumps or control samples. The chemical has been associated with an increased risk of tumors in laboratory rats, Cubist said.

Copyright 2008 by United Press International

Explore further: First newborn screening test approved for rare immune disorder

add to favorites email to friend print save as pdf

Related Stories

Turning deadly chemical agents into harmless soil

1 hour ago

Destroying chemical warfare agents in bulk is a challenge for the military and international community. Current methods of eradication, such as incineration or hydrolysis, create toxic waste that requires ...

The technological path to Mars

2 hours ago

Can the just-flown Orion spacecraft truly get us to Mars? NASA has been portraying the mission as part of the roadmap to the Red Planet, but there are observers who say a human landing mission is an unrealistic ...

Social networks' hidden resources

2 hours ago

People's social networks can be quite extensive, often bigger than they realize. So Brooke Foucault Welles, an assistant professor of communication studies in the College of Arts, Media and Design, says it's ...

Recommended for you

New system targets germs in donated blood plasma

10 hours ago

(HealthDay)—A new system designed to eliminate germs in donated blood plasma and reduce the risk of transmitting a plasma-borne infection has been approved by the U.S. Food and Drug Administration.

Judge halts Alzheimer's drug swap until July

Dec 16, 2014

A federal judge has ordered an Irish drug manufacturer to halt its plans to discontinue its widely used Alzheimer's medication, allegedly in an effort to drive patients to a newer patented drug.

India court blocks Bayer generic drug appeal

Dec 13, 2014

An Indian court has rejected German drug giant Bayer's bid to block a generic version of its blockbuster cancer treatment Nexavar by a local drugmaker, a move hailed by activists on Saturday.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.